Improving drug use for children in the developing world

Archives of Disease in Childhood

Volumn 90, Issue 10, 2005, Pages 1091-1093

  Beggs, S A ^a   Cranswick, N E ^a   Reed, M D ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; CHILD CARE; CHILD DEATH; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; DRUG UTILIZATION; ETHICS; EUROPEAN UNION; HUMAN; PATENT; PRIORITY JOURNAL; REVIEW; UNITED STATES;

ADOLESCENT; CHILD; CHILD HEALTH SERVICES; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; DRUG COSTS; DRUG THERAPY; HUMANS; INFANT; INFANT, NEWBORN; INTERNATIONAL COOPERATION; PEDIATRICS; WORLD HEALTH;

EID: 26044450994     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2005.076703     Document Type: Review

References (24)

1. Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology-drug disposition, action, and therapy in infants and children. N Engl J Med 2003;349:1157-67.
2. Ahmad OB, Lopez AD, Inoue M. The decline in child mortality: a reappraisal. Bull World Health Organ 2000;78:1175-91.
3. WHO. The world health report 2002: reducing the risks, promoting healthy life. Geneva: World Health Organization, 2002.
4. Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year? Lancet 2003;361:2226-34.
5. Morris SS, Black RE, Tomaskovic L. Predicting the distribution of under-five deaths by cause in countries without adequate vital registration systems. Int J Epidemiol 2003;32:1041-51.
6. Quick JD, Hogerzeil HV, Velasquez G, et al. Twenty-five years of essential medicines. Bull World Health Organ 2002;80:913-14.
7. WHO. Essential medicines: WHO model list, 13th edn. Geneva: World Health Organization, 2003.
8. WHO. The selection and use of essential medicines: report of the WHO Expert Committee. Geneva: World Health Organization, 2003, http://www.who.int/ medicines/organization/par/edl/expertcomm13.shtml (accessed 21 May 2004).
9. RCPCH, NPPG. Medicines for children, 2nd edn. London: RCPCH Publications, 2003.
10. Royal Children's Hospital. Paediatric pharmacopoeia, 13th edn. Melbourne: Royal Children's Hospital, 2002.
11. Quick JD. Essential medicines twenty-five years on: closing the access gap. Health Policy Plan 2003;18:1-3.
12. WHO Policy Perspective on Medicines. WHO medicines strategy: 2000-2003. Geneva: WHO, 2000, http://www.who.int/medicines/library/edm_general/6pagers/ PPM01ENG.pdf (accessed 21 May 2004).
13. Commission on Macroeconomics and Health. Macroeconomics and Health. Investing in health for economic development. Geneva: WHO, 2001, http://www3.who.int/whosis/cmh/cmh_report/report.cfm?path=cmh, cmh_report&language=english# (accessed 18 June 2004).
14. Ruxin J, Paluzzi JE, Wilson PA, et al. Millennium project: emerging consensus in HIV/AIDS, malaria, tuberculosis, and access to essential medicines. Lancet 2005;365:618-21.
15. WHO. Selected topics in health reform and drug financing. Geneva: WHO, 1998, http://www.who.int/medicines/library/dap/who-aap-98-3/who-dap-98-3.pdf (accessed 20 April 2005).
16. DFID HSRC. Access to medicines in under-served markets. London: DFID Health Systems Resource Centre, 2004, http://www.dfidhealthrc.org/shared/ publications/Issues_papers/ATM/DFID_synthesis_aw.pdf (accessed 20 April 2005).
17. Tan E, Cranswick N, Rayner C, et al. Dosing information for paediatric patients: are they really "therapeutic orphans"? Med J Aust 2003;179:195-8.
18. Okuonghae HO, Ighogboja IS, Lawson JO, et al. Diethylene glycol poisoning in Nigerian children. Ann Trop Paediatr 1992;12:235-8.
19. Hanif M, Mobarak MR, Ronan A, et al. Fatal renal failure caused by diethylene glycol in paracetamol elixir: the Bangladesh epidemic. BMJ 1995;311:88-91.
20. Singh J, Dutta AK, Khare S, et al. Diethylene glycol poisoning in Gurgaon, India, 1998. Bull World Health Organ 2001;79:88-95.
21. O'Brien KL, Selanikio JD, Hecdivert C, et al. Epidemic of pediatric deaths from acute renal failure caused by diethylene glycol poisoning. Acute Renal Failure Investigation Team. JAMA 1998;279:1175-80.
22. Nahata MC, Pai VB, Hippie TF. Pediatric drug formulations, 5th edn. Cincinnati, OH: Harvey Whitney Books.
23. Trouiller P, Torreele E, Olliaro P, et al. Drugs for neglected diseases: a failure of the market and a public health failure? Trop Med Int Health 2001;6:945-51.
24. Global Forum for Health Research. The 10/90 report on health research 2003-2004. Geneva: Global Forum for Health Research, 2004, http://www. globalforumhealth.org/pages/index.asp (accessed 18 June 2004).